Bottom line
Is LHCFX a good fund? The bottom line
LHCFX is the Class F share class of Lord Abbett Health Care Fund, a managed health care sector mutual fund from Lord Abbett.
Its expense ratio is 0.78% — about $78 a year on every $10,000 invested, cheaper than 64% of health care sector funds we track.
It returned +18.0% over one year, +4.6% a year over five years (as of Dec 31, 2025, per its prospectus).
With $8.6 million in net assets and 61 holdings, its largest position is Eli Lilly & Co (10.4%) and the top 10 make up 42.9% of the portfolio.
What stands out
- No front-end sales load
What to watch
- 12b-1 marketing fee of 0.1% a year
- Small fund ($8.6 million) — small funds are likelier to close
Updated Nov 19, 2026
What LHCFX invests in
The Funds investment objective is to seek long-term capital appreciation.
Under normal conditions, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity and equity-related securities of health care-related companies. The Fund considers health care-related companies to be those companies that operate in, or are related to, the major subsectors of the health care sector, including pharmaceuticals, biotechnology, health care technology, life sciences tools and services, health care equipment and supplies, and health care providers and services. The Funds allocation among these areas will vary based on the portfolio management teams outlook for the particular subsector and the health care sector overall. The Fund normally invests at least 25% of its total assets, in the aggregate, in the following industry groups: health care equipment and services and pharmaceuticals, biotechnology, and life…
From the fund's prospectus (filed Feb 25, 2026).
LHCFX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| LHCFX | +18.0% | +4.6% | — |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2025
What LHCFX costs
On a $10,000 investment, LHCFX's 0.78% expense ratio costs about $78 a year. The prospectus estimates $3,448 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
LHCFX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Eli Lilly & Co | 10.40% |
| 2 | UnitedHealth Group Inc | 5.39% |
| 3 | Johnson & Johnson | 4.96% |
| 4 | Novartis AG | 4.19% |
| 5 | Natera Inc | 3.60% |
| 6 | Gilead Sciences Inc | 3.53% |
| 7 | CVS Health Corp | 3.33% |
| 8 | Guardant Health Inc | 2.61% |
| 9 | Galderma Group AG | 2.60% |
| 10 | Thermo Fisher Scientific Inc | 2.31% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 42.9% of the fund. See all top 25 holdings and asset mix →